Company Profile
Cybin Stock Price, News & Catalysts
- Ticker:
- CYBN
- Exchange:
- AMEX
- Sector:
- Biopharma
- Location:
- Canada and listed in the U
Why the stock is moving
Current closing-price context is not available for CYBN.
Company overview
Business overview
Cybin is a biotechnology company focused on psychedelic-inspired mental health therapeutics. Its story is built around developing new treatments for depression and other psychiatric conditions through psychedelic-derived science.
Geographic Base and Sector Classification
Cybin is headquartered in Canada and listed in the U.S. market. It sits in neuroscience biotechnology with a novel-therapeutics profile.
Business Model Characteristics
The company depends on clinical validation, regulatory progress, and the ability to translate a new therapeutic paradigm into real-world value. Investors usually watch early data, trial design, and capital runway.
Position Within the Biotechnology Landscape
Cybin occupies a speculative but highly visible neuroscience niche within biotech. The stock is sensitive to whether psychedelic-inspired therapy can turn into a durable clinical category.
Future catalysts
- Cybin’s catalysts are psychedelic-neuroscience programs, especially CYB003 and CYB004, where the next clinical or regulatory update can materially move sentiment. The company is still highly dependent on proof of concept.
Recent news
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What does Cybin do?
Cybin is a biotechnology company focused on psychedelic-inspired mental health therapeutics. Its story is built around developing new treatments for depression and other psychiatric conditions through psychedelic-derived science.
On which exchange is CYBN stock listed?
Cybin (CYBN) is associated with AMEX, Canada and listed in the U, Biopharma.
What is Cybin?
Cybin’s catalysts are psychedelic-neuroscience programs, especially CYB003 and CYB004, where the next clinical or regulatory update can materially move sentiment.
Which conditions is Cybin targeting with Cybin?
Cybin is associated with neuroscience based on its company overview and current catalyst commentary.
How does Cybin describe recent progress with Cybin?
Cybin’s catalysts are psychedelic-neuroscience programs, especially CYB003 and CYB004, where the next clinical or regulatory update can materially move sentiment.
What is CYB003?
Cybin’s catalysts are psychedelic-neuroscience programs, especially CYB003 and CYB004, where the next clinical or regulatory update can materially move sentiment.
What should investors watch for with CYB003?
Cybin’s catalysts are psychedelic-neuroscience programs, especially CYB003 and CYB004, where the next clinical or regulatory update can materially move sentiment.
What is CYB004?
Cybin’s catalysts are psychedelic-neuroscience programs, especially CYB003 and CYB004, where the next clinical or regulatory update can materially move sentiment.